Sussex Partnership NHS Foundation Trust

• A new clinical trial published in Lancet Psychiatry demonstrates that mindfulness-based cognitive therapy (MBCT) significantly improves symptoms in patients with difficult-to-treat depression compared to standard care. • The eight-week MBCT program delivered via videoconference was found to be cost-effective at less than £100 per person, potentially saving healthcare systems money while providing a viable treatment option for patients who haven't responded to conventional therapies. • Researchers from the University of Surrey, University of Exeter, and University of Sussex report that MBCT's effectiveness is comparable to antidepressants, offering new hope for the approximately 50% of depression patients who remain symptomatic after completing standard psychological treatments.

Sussex Partnership NHS Foundation Trust

Mindfulness-Based Cognitive Therapy Shows Promise for Treatment-Resistant Depression